James Mackaness serves as the Chief Financial Officer at Soleno Therapeutics Inc., a position he has held since joining the company in 2021. With a robust background in finance and biotechnology, Mackaness brings a wealth of experience to his role. Prior to Soleno, he held the position of CFO at several other biotech firms, including OncoSec Medical Incorporated, where he played a pivotal role in steering the company through various stages of growth and development. His strategic financial leadership has been instrumental in navigating complex market landscapes and fostering sustainable growth. At Soleno Therapeutics, Mackaness is responsible for overseeing all financial aspects of the company, including financial planning and analysis, accounting, and investor relations. His strategic vision has been crucial in driving the company’s mission to develop novel therapeutics for the treatment of rare diseases. Under his leadership, Soleno has successfully raised significant capital to fund its research and development initiatives, positioning the company for future success. Mackaness’s ability to forge strong relationships with investors and stakeholders has been key to enhancing the company’s financial stability and market presence. Mackaness holds a Bachelor’s degree in Accounting and Finance from the University of Manchester and is a qualified Chartered Accountant. His career is marked by notable achievements, such as leading successful IPOs and financings that have enabled companies to advance their clinical programs. His expertise in financial strategy and his commitment to the biotech industry make him a vital asset to Soleno Therapeutics as it continues to innovate and grow in the competitive landscape of rare disease treatment.